Trademarkia Logo

Australia

AU$
EVOBRIG
Protected: Registered/protected

Last updated on 22 Mar 2025

Owner Info

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

1878117 filed on 8 Aug 2017

Correspondent

Troutman Pepper Locke LLP

c/o IP Services NYC,,

875 Third Avenue,

UNITED STATES OF AMERICA

EVOBRIG

Classification Information


Class [005]
Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inf Read More

Mark Details


Serial Number

1878117

Registered On

8 Aug 2017

Renewal On

8 Aug 2027

Mark Type

WORD

Priority Claim (Convention Details)


Date

28 Jun 2017

Mark Type

DE

Legal History


Show more

Status DateAction Taken
22nd Mar 2025Full Assignment - Subsequent Owner Registered Published
20th Mar 2025Full Assignment Requested
27th Feb 2025Amendment to International Registration Contact Requested
17th Sept 2020Amendment to International Registration Contact Requested
1st Feb 2018IP Right Registration Published
24th Jan 2018Application Status
24th Jan 2018Register Trade Mark
22nd Nov 2017Amendment to Application/Registration
16th Nov 2017IP Right Acceptance Published
13th Nov 2017Amend Status from Awaiting Advertisement